Forte Biosciences, Inc. (FBRX) Institutional Ownership

Ownership Summary

Forte Biosciences, Inc. (NASDAQ:FBRX) is held by 35 institutional investors per 13F filings through June 2024.

• These investors held 1210.8% of outstanding shares in June 2024, down from 1404.5% in March 2024.
• They decreased total shares held in FBRX by -13.58% quarter over quarter, and investors in Forte Biosciences increased 9.38% from a year ago.
• Among the 35 funds, 10 bought more Forte Biosciences shares, 8 sold down, and 17 held their ground.
• The aggregate institutional position in Forte Biosciences amounted to 22.34Mn shares as of June 2024, down by 3.51Mn shares quarter on quarter, and up 18.85Mn shares year over year.
• Janus Henderson Group Plc holds the largest position in FBRX at 2.38Mn shares as of June 30, 2024, or 128.77% of shares outstanding.
• The largest buyers of Forte Biosciences for the quarter ending June 2024 were MPM BioImpact LLC (1.0Mn), Janus Henderson Group Plc (950.34K), ADAGE CAPITAL PARTNERS GP, L.L.C. (616.67K), VANGUARD CAPITAL MANAGEMENT LLC (531.69K), Morgan Stanley (429.77K).
• The largest sales of FBRX for the quarter ending June 2024 came from FRED ALGER MANAGEMENT, LLC (187.01K), Jain Global LLC (186.84K), Ikarian Capital, LLC (181.03K), Goldman Sachs Group Inc (82.57K), Ameriprise Financial Inc (41.24K).
• Per Business Quant, the top 10 investors in FBRX for the quarter ending June 2024 include Janus Henderson Group Plc (2.38Mn), Federated Hermes, Inc. (1.77Mn), FRED ALGER MANAGEMENT, LLC (1.27Mn), ORBIMED ADVISORS LLC (1.2Mn), Affinity Asset Advisors, LLC (1.01Mn), MPM BioImpact LLC (1.0Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (950.0K), VANGUARD CAPITAL MANAGEMENT LLC (531.69K), Morgan Stanley (500.3K), Cable Car Capital, LP (400.0K).